packageBelimumab

belimumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Belimumab is a monoclonal antibody immunosuppressant used to treat systemic lupus erythematosus, including lupus nephritis. It is authorised in the European Union and is an approved medicine, used mainly for lupus.

Summary written by glm-5.3-flash from Wikidata Q1996249 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:belimumab
ATC codes:L04AG04
DrugBank:DB08879
Wikidata:Q1996249
molar mass:147000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown